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WITH AEROMONAS HYDROPHILA 
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Chairman: Prof . Mohd . Shariff Mohd. Din, Ph. D 
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Immunomodulation of ENCAP in red tilapia hybrid 
against Aeromonas hydrophila was studied. Different 
concentrations of ENCAP (0, 500, 750 and 1000 mg/kg of 
feed) were fed to different groups of fish and later 
challenged by intraperitoneal injection of 8 x 108 CFU/ml A. 
hydrophila. The non-specific immune response was determined 
after one, two, four and seven days post bacterial 
challenge using haematologicaJ and serological assays such 
as haematocrit, WBC counts, potential killing activity of 
neutrophils and other phagocytic cells by NBT, lysozyme 
activity and total plasma protein. Different concentrations 
of ENCAP showed different levels of immunopotentiation. 
xvii 
Hematocrit leve l s  and WBC counts decreased in  a l l  the 
groups due to m igration of erythrocytes and leukocytes to 
the i n f ected areas . Probably , toxins re leased by the 
bacter i a  a lso contr ibuted to these lowered l eve l s . 
Neutrophi l s  and oth er phagocytic ce l ls demonstrated an 
increase in the pot ent i a l  k i l l ing activity . Lysozyme 
act ivity a lso  increased in f ish fed w i th ENCAP , wh i le total  
p l a sma prote i n  decreased brought about by the abnorma l 
function o f  the l iver to synthes i z e  prote i n . Based on these 
ce l lu lar and humora l factors , f i sh f ed w ith 750 mg / kg EN CAP 
had a cons istent ly h igher immune response . Fish fed w ith 
500 mg / kg and 1000 mg / kg showed a lower immune response 
whi ch suggests s J ight immunopotent iat ion and m i ld 
immunosuppress ion , respect ive ly . 
H i stopathology showed that both the control and f i sh 
f ed w ith d i f ferent concentrat ions of ENCAP exh ib ited 
varyi ng les ions in the spleen , liver , pancreat ic t i s sue and 
k i dney . However f i sh fed with ENCAP showed a s ign i f icant ly 
h i gher surv ivabi l ity. Resu lts of this study indicated that 
ENCAP caused immunomodu lation. The enhanced non-spec i f ic 
response contr i buted to the increa sed survivabi l ity .  
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Immunomodulasi oleh ENCAP pada hibrid tilapia merah 
terhadap Aeromonas hydrophila telah dikaji. Kepekatan ENCAP 
yang berbeza (0, 500, 750 dan 1000 mg/kg makanan) telah 
diberi kepada beberapa kumpulan ikan dan kemudian dicabar 
dengan suntikan intraperitoneal 8 x 108 CFU/ml A. 
hydrophila. Tindakbalas tidak specifik imun telah 
ditentukan pada hari pertama, kedua, keempat dan ketujuh 
selepas suntikan bakteria dengan menggunakan hematologikal 
dan serologikal asei seperti hematokrit, pengiraan sel 
darah putih, potensi aktiviti membunuh neutrofil dan se1-
sel fagositik lain secara NBT, aktiviti lisozim dan jumlah 
protein plasma. Kepekatan ENCAP yang berbeza menunjukkan 
tahap immunopotensasl yang berbeza. 
xix 
Paras hematokrit dan jumlah WBC berkurangan dalam 
semua kumpulan disebabkan oleh migrasi eritosit dan 
leukosit ke kawasan yang dijangkiti. Mungkin, toksin yang 
dilepaskan oleh bakteria menyumbang kepada tahap yang 
rendah tersebut. Neutrofil dan sel-sel fagositik lain 
menunjukkan peningkatan potensi aktiviti membunuh. Aktiviti 
lisozim telah juga ditingkatkan pada ikan yang diberi makan 
ENCAP. Sementara jumlah protein plasma berkurangan akibat 
dari fungsi abnormal hati mengsintesiskan protein. 
Berdasarkan faktor-faktor sellular dan humoral, ikan yang 
diberi makan 750 mg/kg ENCAP mempunyai tindakbalas 
immunisasi tinggi yang berpanjangan. Ikan yang diberi makan 
500 mg/kg menunjukkan tindakbalas immunisasi rendah yang 
mencadangkan sedikit immunopotensasi dan manakala pada 1000 
mg/kg menunjukkan immunosupresi. 
Histopatologi menunjukkan kedua-dua kawalan dan ikan 
yang diberi makan dengan kepekatan ENCAP yang berlainan 
mempamirkan lesi yang berbeza dalam limpa, hati, tisu 
pankreatik dan ginjal. Walaubagaimanapun, ikan yang diberi 
makan dengan ENCAP menunjukkan kemandirian yang jelas 
tinggi. Keputusan kajian ini menunjukkan bahawa ENCAP 
menyebabkan immunomodulasi. Tindakbalas tidak specifik yang 
diransang menyumbang kepada peningkatan kemandirian. 
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CHAPTER I 
GENERAL INTRODUCTION 
Aquaculture plays a vital role in the production of 
fish and other fishery products. Aquaculture has expanded 
around the world due to the increasing demand of protein 
from the growing human population and the decline of 
available natural aquatic resources. However, the rapid 
expansion and intensification of f ish farming lead to the 
occurrence of various economically important diseases. 
Consideration on the intimate relationship between the 
fish, pathogen and environment seems to be neglected. The 
unwise increase of stocking density together with the 
deterioration of the aquatic environment can cause stress 
to the cultured fish. stress lowers the resistance of the 
fish thereby giving chance to opportunistic pathogens to 
become invasive. Thus fish ln this scenario, will 
inevitably succumb to diseases cause by either viruses, 
bacteria, parasites and fungi. 
To overcome such problems, fish culturists became more 
dependent on the use of chemotherapeutic agents. But with 
the limitation of approved chemotherapeutic products, 
overused or misused of antibiotics generate the risk of 
1 
2 
bacterial resistant pathogens and the problems of drug 
residues in the environment and f ish products (Ellis, 1988; 
Ghittino et al. , 1984; Anderson, 1992; Baticados and 
Paclibare, 1992; Nikl et al. , 1993) . Rijkers et al. (1981) 
reported that prolonged used of oxytetracycline cause 
depression of the humoral and cellular immunity in common 
carp. Some chemicals such as malachite green, a known 
parasiticide and pyridylmercuric acetate, an effectjve 
fungicide cause cancer and mercury accumulation in tissues 
respectively (Anderson et al. , 1984). 
The use of vaccine to stimulate the production of 
antibody against specific pathogen has been studied. The 
first experimental vaccination in fish was reported by Duff 
in 1942 against furunculosis using killed Aeromonas 
salmonicida given orally. But since then only few vaccines 
have been proven to be effective on commercial scale. Other 
vaccinations that have been successfully done 
experimentally were not reliably reproduced even using 
other techniques of administration and antigen preparation 
(Ellis, 1988). Although vaccination is a valuable approach 
for disease prevention (Alderman and Michel, 1991) its 
usefulness is limited by their specificity, lack of 
availability and high cost to produce commercially (Ellis, 
1988; Yoshida et al. , 1993). 
3 
The constraints on the use of chemotherapeutic agents 
and vaccines in f ish farming further the development of 
more effective ways and means to protect the f ish from 
various disease causing organisms. The use and application 
of immunostimulants for protecting the fish against 
diseases has been attempted. Immunostimulant elevates the 
non-specific defense mechanism or the specific immune 
response (Anderson, 1992). This may be administered alone 
or in combination with vaccine to activate the non-specific 
defense mechanism as well as heightening the specific 
immune response. 
The non-specific defense mechanism is the first line 
of defense which constitutes the protective barriers such 
as skin and scales, humoral factors in mucus and sera such 
as lysozymes, C-reactive protein, transferrin and 
interferon, and the cellular factors such as phagocytic 
cells, neutrophils and macrophages (Fletcher, 1986; 
Roberts, 1989; Robertsen et al. , 1990; Kaige et al., 1990; 
Anderson, 1992). On the otherhand, the specif ic defense 
mechanism is responsible for initiating and mediating the 
humoral, cell mediated immunity (CMI) and the memory. The 
humoral immunity refers to the production of soluble 
antibody, whereas the CMI refers to responses which are 
mediated by lymphocytes and macrophages and the memory 
constitutes an adaptive change in the lymphoid cells 
causing an enhanced magnitude with subsequent challenge by 
the same antigen (Roberts, 1989). 
4 
The use of immunostimulants is being intensified in 
the areas of cancer and AIDS (Acquired immunodef iciency 
syndrome) research (Fudenberg and Whitten, 1984; Azuma and 
Jolles, 1987; WHO, 1990 as cited by Anderson, 1992). It 
activates macrophages, T- and B-Iymphocytes, and natural 
killer cells that increase the body's ability to destroy 
tumour cells (Raa et al., 1992). Immunostimulants were also 
used for activating early protection against diseases in 
domestic animals (Kehrli et al., 1990). 
Immunostimulants can be obtained from a very diverse 
natural sources and a large number have been made by 
chemical synthesis with natural products as structural 
models (Raa et al., 1992). Different substances have been 
tested to stimulate immune response in fish. Glucans, a 
long-chain polysaccharides extracted from yeast given 
parenterally or orally were evaluated in fish for their 
ability to enhance protection against different bacterial 
pathogens (Yano et al., 1989; Robertsen et al., 1990; Raa 
et al. , 1992; Chen and Ainsworth, 1992; Nikl et al., 1993; 
Jeney and Anderson, 1993). 
Some drugs such as levamisole, quaternary ammonium 
compound (QAC) and short chain polypeptide (1SK) affect the 
non-specific defense mechanism activities (Jeney and 
Anderson, 1993). 1mmunoactive peptide FK 565 (Kitao and 
